Welcome to our dedicated page for Astera Labs SEC filings (Ticker: ALAB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Astera Labs's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Astera Labs's regulatory disclosures and financial reporting.
Astera Labs, Inc. reported that its General Counsel and Secretary, Philip Mazzara, received an equity award in the form of restricted stock units. On February 6, 2026, he was granted 5,893 RSUs at a price of $0 per share under the 2024 Stock Option and Incentive Plan.
These RSUs vest 25% on February 15, 2027, with the remaining units vesting in 12 equal quarterly installments, as long as he continues his service with the company. Each RSU converts into one share of common stock upon vesting, bringing his directly owned common shares to 142,933 after this grant.
Astera Labs, Inc. announced that Chief Financial Officer Michael Tate will retire from the CFO role effective March 2, 2026, and will remain with the company as Strategic Advisor to the CEO until September 1, 2026 under a transition services agreement. The company states there were no disagreements with Mr. Tate and that his retirement is not related to its operations, policies, or practices.
The board appointed Desmond Lynch as the new Chief Financial Officer effective March 2, 2026. His offer letter provides a $500,000 annual base salary, an annual target bonus equal to 95% of base salary, and equity awards comprising $6,000,000 in restricted stock units, a $1,000,000 supplemental RSU grant, and $2,000,000 in performance stock units, all subject to time-based or performance-based vesting and continued employment.
Astera Labs reported a breakout 2025 with rapid AI-driven growth. Fourth-quarter revenue reached $270.6 million, up 17% sequentially and 92% year-over-year, with GAAP gross margin of 75.6% and GAAP net income of $45.0 million, or $0.25 per diluted share.
For full-year 2025, revenue rose 115% year-over-year to $852.5 million, with GAAP net income of $219.1 million and diluted EPS of $1.22. Non-GAAP operating margin was 39.2%, reflecting substantial profitability after excluding stock-based compensation and acquisition costs.
The company is ramping its Scorpio X-Series smart fabric switches with hyperscaler customers, expanding custom NVLink Fusion connectivity, and launching Leo CXL Smart Memory Controllers. For Q1 2026, it guides revenue to $286–$297 million and GAAP diluted EPS of $0.36–$0.38, with non-GAAP EPS of $0.53–$0.54.
Astera Labs, Inc. entered into a Transaction Agreement with Amazon.com, Inc. and issued a Warrant to Amazon.com NV Investment Holdings LLC for up to 3,262,299 shares of common stock at an exercise price of $142.82 per share. The Warrant runs through February 5, 2033 and allows cashless exercise.
Shares under the Warrant vest based on performance conditions tied to specified payment tranches of up to $6.5 billion for Astera Labs’ smart fabric switch, signal conditioning, and optical engine products purchased by Amazon and its affiliates. The deal includes customary anti-dilution adjustments, registration rights, and transfer restrictions, and was structured as an unregistered private offering under Section 4(a)(2) of the Securities Act.
Astera Labs, Inc. reported that Chief Accounting Officer and VP, Finance Cota Germaine received two equity awards on February 2, 2026. The awards total 24,933 restricted stock units (RSUs), each RSU representing one share of common stock.
One grant covers 21,817 RSUs that vest 25% on February 15, 2027, with the remaining 75% vesting in 12 equal quarterly installments afterward, contingent on continued service. A second grant of 3,116 RSUs vests 100% on February 15, 2027, also subject to ongoing service. Following these grants, Germaine directly holds 24,989 shares of common stock.
Astera Labs, Inc. insider ownership update: Officer Cota Germaine, who serves as Chief Accounting Officer and Vice President, Finance, filed an initial ownership report. As of January 20, 2026, Germaine beneficially owns 56 shares of Astera Labs common stock, held directly. This filing is a standard Form 3, establishing baseline insider ownership for this executive.
BlackRock, Inc. has filed an amended Schedule 13G reporting a passive ownership stake in Astera Labs Inc. common stock. As of 12/31/2025, BlackRock reports beneficial ownership of 10,507,515 shares, representing 6.2% of Astera Labs’ outstanding common stock. BlackRock has sole voting power over 9,904,532 shares and sole dispositive power over 10,507,515 shares, with no shared voting or dispositive power.
The filing states that the shares are held in the ordinary course of business and not for the purpose of changing or influencing control of Astera Labs. Various underlying clients and accounts have rights to dividends and sale proceeds, but no single client has more than five percent of the company’s total outstanding common shares.
Astera Labs, Inc. appointed Germaine Cota, age 45, as Chief Accounting Officer and Vice President of Finance, effective January 20, 2026. She will serve as the company’s principal accounting officer for SEC reporting purposes.
Cota brings extensive finance and accounting experience, having most recently served as Senior Vice President, Finance & Accounting and principal accounting officer at BILL Holdings, Inc., with prior senior roles at 8x8, Inc., Mercari, Inc., and LinkedIn, plus nearly 10 years at Ernst & Young. She holds a B.S. in Accounting from Santa Clara University and is a California CPA.
Her employment terms include a $375,000 annual base salary, a target annual performance bonus equal to 50% of base salary, and a one-time hiring or relocation bonus of $130,000, subject to repayment if employment ends for specified reasons within a year. She is also granted restricted stock units with opportunities to receive $3,500,000 in common stock under a long-term award and $500,000 under a supplemental award, vesting over four years and one year, respectively, contingent on continued employment.
Astera Labs, Inc.'s director and President & COO reported gifting common stock held through an estate-planning trust. On 12/01/2025 and 12/02/2025, a trust labeled “Trust 1” made two bona fide gifts of 71,000 shares each of Astera Labs common stock, reported at a price of $0 per share using transaction code G for gifts.
Following these transactions, the reporting person is shown as indirectly holding 5,864,213 shares through Trust 1, 695,000 shares through “Trust 2,” and 695,000 shares through “Trust 3,” along with 1,599,750 shares held directly. The trusts are described as estate planning vehicles, and the reporting person disclaims beneficial ownership of the trust-held shares except to the extent of any pecuniary interest.
Astera Labs, Inc. (ALAB) reported an insider stock sale by a director on a Form 4. On 11/20/2025, the reporting person sold a total of 2,500 shares of common stock in a series of market transactions at weighted average prices ranging from about $142.09 to $159.11 per share. The filing states these sales occurred automatically under a pre-arranged Rule 10b5-1 trading plan adopted on May 28, 2025, which is designed to allow systematic selling regardless of day-to-day market conditions. After these transactions, the director directly owned 94,851 shares of Astera Labs common stock. No derivative security transactions were reported.